Minjeong Ko

825 total citations
10 papers, 266 citations indexed

About

Minjeong Ko is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Minjeong Ko has authored 10 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Minjeong Ko's work include RNA modifications and cancer (4 papers), Cancer Genomics and Diagnostics (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Minjeong Ko is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer Genomics and Diagnostics (3 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Minjeong Ko collaborates with scholars based in United States, South Korea and South Africa. Minjeong Ko's co-authors include Sanghyuk Lee, Insu Jang, Daeun Ryu, Sooyoung Cho, Yukyung Jun, Hyeshik Chang, V. Narry Kim, Wankyu Kim, Sang‐Hyun Lee and Jaesang Kim and has published in prestigious journals such as Nucleic Acids Research, Science Advances and American Journal Of Pathology.

In The Last Decade

Minjeong Ko

10 papers receiving 262 citations

Peers

Minjeong Ko
Comparison fields: 5 of 42
  • Molecular Biology 213
  • Cancer Research 169
  • Pulmonary and Respiratory Medicine 29
  • Oncology 29
  • Genetics 20
Namhee Yu South Korea
Kun Meng China
Huajun Qu China
Nuno Saraiva-Agostinho Portugal
Danxi Zhu China
Marica Rosaria Ippolito Italy
Zuxianglan Zhao China
Ryan J. Quinton United States
Chun-Lin Lin United States
Namhee Yu South Korea View profile →
Citations per field, relative to Minjeong Ko
Minjeong Ko · 1×
Citations per year, relative to Minjeong Ko
Minjeong Ko · 1×

Countries citing papers authored by Minjeong Ko

Since Specialization
Citations

This map shows the geographic impact of Minjeong Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjeong Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjeong Ko more than expected).

Fields of papers citing papers by Minjeong Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjeong Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjeong Ko. The network helps show where Minjeong Ko may publish in the future.

Co-authorship network of co-authors of Minjeong Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Minjeong Ko. A scholar is included among the top collaborators of Minjeong Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minjeong Ko. Minjeong Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
# Work Indexed citations
1 16
2 4
3 4
4 3
5 9
6 17
7 1
8 14
9 132
10 66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026